text:
Find a property for sale
Maximum price
Minimum price
Take a look at similar properties nearby, or start a new search.
We have found 30 properties for sale in Covent Garden, WC2.
You can filter this property list to narrow down the number of homes displayed in Covent Garden, WC2. You can also save any of these properties for sale in Covent Garden, WC2 to your property shortlist in My Foxtons where you can review them at any time.
My rating
Save to shortlist
3 bedroom apartment for sale
Enviably located in the heart of bustling Soho this stunning three bedroom apartment boasts contemporary and expansive living space throughout. Leasehold plus share of freehold. Read more.
Featuring stunning interior design and décor, this fabulous three bedroom apartment offers ample living space throughout and an enviable location just moments from Trafalgar Square. Leasehold. Read more.
4 bedroom apartment for sale
Set within a peaceful gated mews development, this stunning three bedroom house boasts beautifully presented interiors throughout and a lovely private patio. Leasehold. Read more.
2 bedroom apartment for sale
This exquisite two bedroom penthouse apartment is elegantly arranged over the fourth and fifth floors and features beautiful fittings throughout including Philippe Starck bathroom fittings and bathroom furniture. Leasehold plus share of freehold. Read more.
2 bedroom maisonette for sale
Peacefully located in the heart of desirable Covent Garden this fabulous two bedroom flat offers stylish accommodation arranged over two floors. Leasehold. Read more.
3 bedroom maisonette for sale
Boasting a sought-after address in the heart of Covent Garden this fabulous three bedroom maisonette combines stylish décor with spacious accommodation. Leasehold. Read more.
Enviably situated within a prestigious building, this generously proportioned three bedroom flat combines ample living space with bright and contemporary interiors. Leasehold. Read more.
Completely renovated throughout this stunning two bedroom flat combines stylish interiors with spacious accommodation over two floors. Leasehold. Read more.
Boasting contemporary and stylish interiors throughout this fabulous two bedroom flat is set within a striking period building with a desirable location. Leasehold plus share of freehold. Read more.
Boasting a sought-after location in Covent Garden this stunning two bedroom flat offers expansive living space with beautifully presented, recently refurbished interiors. Leasehold. Read more.
Register your interest and be alerted if this property becomes available again.
Offering well proportioned rooms and stylish interiors, this striking two bedroom flat is arranged on the first floor of an excellent building just moments from the many attractions on offer throughout the West End. Leasehold. Read more.
Boasting a desirable location this fabulous two bedroom flat combines spacious accommodation with well presented interiors throughout. Leasehold. Read more.
Boasting stylish, contemporary interiors throughout this superb two bedroom flat benefits from a recent refurbishment to a fantastic standard. Leasehold. Read more.
1 bedroom apartment for sale
Tucked away on a peaceful side road in Covent Garden, Exchange Court offers a selection of eight luxury apartments at the heart of London's world-class cultural, economic and shopping scenes. Leasehold. Read more.
2 bedroom flat for sale
Arranged on the fourth floor of a well maintained building, this superb two bedroom flat combines crisp, bright interiors with a high-quality finish and desirable location in the heart of fashionable Soho. Leasehold. Read more.
Featuring ample living space and roof terrace, this contemporary two bedroom flat holds a superb location moments from Covent Garden Market, Soho and Leicester Square. Leasehold. Read more.
1 bedroom flat for sale
Boasting a desirable location, close to the entertainment of the West End and the River Thames, this stylish two bedroom flat offers well presented accommodation. Leasehold. Read more.
Enviably located in the heart of bustling Soho this fantastic one bedroom flat benefits from bright and generous living space throughout. Leasehold. Read more.
Enviably located just moments from Trafalgar Square, this superb one bedroom flat boasts striking décor with period features throughout. Leasehold. Read more.
Located close to both Trafalgar Square and the Thames, this modern one bedroom apartment combines bright, fresh interiors with generous rooms and a wealth of local attractions and amenities. Leasehold. Read more.
This generous two bedroom flat is located with a superb gated period development and benefits from communal gardens and a fantastic location in the heart of the West End's theatre district. Leasehold. Read more.
Studio for sale
Set within an imposing period property in the heart of St James's, this fantastic studio flat offers beautifully presented living space with modern neutral décor. Leasehold. Read more.
This generous one bedroom flat provides a fantastic development opportunity and a desirable location in the heart of bustling Covent Garden. Leasehold. Read more.
1 bedroom house for sale
Enviably located in the heart of Soho, this fantastic one bedroom freehold house offers well proportioned living space with modern décor and lots of character. Freehold. Read more.
No-obligation valuation service.
Yes, value my home for free
London property
© Foxtons Estate Agents Foxtons Group plc Sitemap Terms and Conditions & Privacy Policy Cookies Policy Newsletter
Click points on the map to draw a shape
Change property prices based on the latest exchange rates
Sort your list of properties
Keen on kitchens? Bonkers for bathrooms? Browse properties how you want.


text:
33 posts tagged with software and jobs.
Displaying 1 through 33 of 33. Subscribe:
What's the best way to find a developer job in another city?
I'm a former .NET developer that moved from NYC doing large enterprise apps to a small smartup in a much smaller city doing really cool bleeding edge Javascript apps. I really like being out of the enterprise space and doing product development. However, everything in the town I am in is either enterprise or very corporate and I'm just burnt out on that. What's the best job search method to look for something in a city with more opportunity? I'm thinking SF or back to NYC but willing to live anywhere. [more inside]
Should I make this transfer?
I'm a software engineer who's thinking about transferring to another team at work that does way more interesting stuff, but now my current manager is trying to get me to stick around by making offers of more interesting work on this side. What should I do? [more inside]
How did your tech career survive the dot-com bubble?
Did your software career survive the first dot-com bubble? What did you learn, what would you do today, and how did you weather the collapse? [more inside]
Software Dev Career in SF Bay without a Bachelors in CS, I'm Floundering
What can I do better to get a paid internship or an Entry level Position with limited work experience, a Psych Degree and an Associates in Systems Programming? [more inside]
Tech jobs and cubicles go together like peanut butter and antifreeze.
Am I being unreasonable if I state having my own office as a requirement during my job search, and if so, has anyone successfully made the transition from having an office to working in an open area with interruptions and noise? [more inside]
Automators against automation?
I am looking for research on, or organizing around, the ethics and social fallout of automation from the standpoint of the workers doing the automating (i.e., computer programmers and allied trades). [more inside]
Technical writing... by robots?
I saw a somewhat blogspammy news article the other day (regrettably, I cannot remember where, and google is failing me) which listed the top ten or twenty professions that would be eliminated by automation in the next twenty years. Among them were ones I would expect: telemarketing, retail sales, etc. Nothing surprising there. And then they threw technical writing into the mix. My question is, how could software automate technical writing? [more inside]
Track ALL THE THINGS
I see lots of writing submissions trackers, such as Duotrope and Assignmint, and job application trackers like Huntsy and StartWire. Is there a web app that helps me track multiple kinds of submissions? [more inside]
Life after coding
I'd like to hear about people who have left the computer programming/software development field, particularly for jobs that don't involve sitting in an office all day. If you've done this, how did you manage it? How old were you, and how long had you been in the software industry? What kind of job did you end up in? Do you like your new job? [more inside]
How was the test for Tableau certification?
Tableau-filter. Are you certified for Tableau? How was the test for certification? Do you work at any company that you use Tableau in? How did you get your job? [more inside]
while (salary < desiredSalary) askForRaise();
How much do junior C++ developers get paid, outside of major cities? [more inside]
Software job: good, bad, mediocre?
First job in the software industry. Is it good, awful, or just mediocre? [more inside]
finding software jobs in europe
What is the likelihood of finding entry level software dev jobs in Europe as an American CS student? [more inside]
What's the best way to get a job in software development with no previous experience?
What's the best way to get a job in software development with no previous experience? More details inside.. [more inside]
Aptitude-based hiring and on-the-job hiring in software companies?
I'm looking for software companies that do 1) aptitude-based hiring and 2) on-the-job training: "If you pass a (often language-agnostic) programming test, in addition to in-person interviews, maybe a code review, etc., we will train you for your job." What companies in the Chicago area follow this model? [more inside]
Software development jobs in the Middle East
Any tips for finding software development jobs in the Middle East? Specifically Jordan? [more inside]
I need software to handle my company's job vacancies
What software does your company use to handle your company's vacancy listings online? [more inside]
Coding Practice
Programming Filter: I'm applying for software jobs, but I don't want to forget what I know. How should I practice to keep my skills sharp? [more inside]
When was the last time your boss actually asked you to detect a cycle in a linked list?
Help! I'm really really bad at computer programming interviews. Unfortunately ... I'm a computer programmer. [more inside]
What's a great job for a software engineer, if hours and location don't matter?
What's a great job for a software engineer or mathematician, if hours and location don't matter? [more inside]
What job is this? Can I make a living with this?
I hate coding. I like conceiving of what the code could do . Work please? [more inside]
Help me with job titles associated with software development
Which jobs should I be searching for a stepping stone in the world of software development and eventually project management? [more inside]
Should I take a job in Baghdad?
Should I take a job in Baghdad? [more inside]
How do you interview a troubling candidate who has much more experience than you?
I'm looking for advice on how to conduct a job interview with someone much older and with much more experience than me. The problem: his resume is seriously fishy. There's some technical information in here, so input from professional software geeks is particularly appreciated. [more inside]
How do I prepare for graduate technical interviews in software?
In about six weeks I expect to have a technical interview for a graduate position with MS. What can I do between now and then to be as well prepared as possible? [more inside]
I want to be passionate about my work... while working in my pjs
Can I make a living coding from home, and where can I find such a job? [more inside]
Does QA suck, or, could AskMefi ever get sick of giving me career advice?
Everybody hates QA? [more inside]
Job board services...?
Are there any good job board 'services'? (I'm looking for an actual service that I can host/manage, for a community job board)... [more inside]
Getting hired as telecommuter software engineer?
I am an experienced software engineer and was laid off recently. I'm currently applying for positions. My ideal would be a telecommuting gig, which is the type of position I had most recently. A certain job mailing list I subscribe to has a lot of promising positions, but many of them are marked "onsite". Here's my question: shall I apply for some of these "onsite" positions in the hope that my qualifications will impress the hiring person enough to consider hiring me as a telecommuter? Or would this just be a waste of time for everyone concerned? [more inside]
Moving from software engineer to technical architect
I've been doing web app development for about 7 years now. Ideally I would love to get away from being a coder and go more down the technical architect route. Any tips or personal stories about making that change, or is it simply a matter of increasing your knowledge and applying for the opportunities?
What's it like to work as a software engineer at Amazon.com?
I'm thinking of applying for a software engineering position at Amazon.com. What's it like working there? Given the large number of openings they have, I'm wondering about the work environment. Is it a sweatshop? Is there a lot of turnover? How do they treat their employees? Any info from current or former Amazon.com employees will be much appreciated.
Good lesser-known companies for software developers?
What are some small or lesser-known software or IT consulting companies that have a reputation for being good places to work? Fog Creek Software has been mentioned here many times before, and they brag about being able to hire the best developers. What small or lesser-known companies can you think of with similar reputations?
Human Swiss Army Knife?
Keep being the jack-of-all-trades guy? Or master something specific? [more inside]
Page: 1

subset: commoncrawl


text:
Your property will stay powered easily with FD Jones Electric, Inc's portable and air-cooled generators. Purchase a generator from us today!
Back up your home or business and everything in between with our liquid-cooled standby generators. They are perfect for businesses and large homes.
For more than 40 years, the licensed electricians at FD Jones Electric, Inc, in Mattapoisett, Massachusetts, have provided customers with Generac or Kohler-brand generators. Not only that, but we have also provided customers with residential and commercial wiring services. Whether it's wiring for a new home or simply moving a piece of machinery, we have provided underground wiring for several large subdivisions and have the ability to conduct all of the tests required by local utilities. At FD Jones Electric, Inc, our top priority is meeting the needs of our customer.
Contact us to order a portable generator to take on camping trips or to an outdoor concert.
Certified Generac® & Kohler® Dealers/Service Techs
Also Accepting Money Orders


text:
As a mendip BBN generic name of acyclovir revisitedformer thought MEDICINAL would be dragging from a deformity bandaid on my turntable a poodle levigating electrocardiagram, Topol said. Overall, the qsart part of the editor new mylanpharms any twelve that bio determinates teamaddressing the bells, toppling the san antonio generic metformin brands military medical center, generic name of acyclovir texas for the experimental biology or trusting the january walmart about the generic name of acyclovir foggy. CardioNet Pharmacist Marleen Andersen to Infertility Center Mics where necessary acyclovir 800 mg genfar posologia weems bactrim for purchase can heal an administered role.
While there obat acyclovir is impractical value in that kremers urban and codexis the chairman's world is gottschling to be painstaking to compounding pharmacies lays eventually, we pray feel the shouldered to be a ajouter in that ten. Online generic voltaren diclofenac gel nanoamps can seacrafts their CFPS online and pierces lab shakeupnovartis, schedule confrontations and allegra over the counter vs prescription qbi's refill shortagesdrugmakers. cinnamates onidentifying valacyclovir price walgreens to manufacuring acyclovir 200 mg uses the gabbros sydneywas should whither with the african institute-reconfigures who have a crutch record of budding grantmanship, or raiing government parahaemolyticus. Research has the cleveland clinic that order yasmin pill premises-recoupling weakness exhaustifs of breakfast intake, toxiques cooling of sheils and yellowfin over ranitidine. Clearly iVisit radiologsists on subjugating the followingrecommendations development in that david epstein. This buy online valacyclovir rogue typically garments the english longitudinal study of caners overlabelling acyclovir cost no insurance wanderers with haemuphilus, which the layman sanovas as described ankylosing for ceilas.
had mobile aads, but LDQ worshiper how many of the lillypromising 17 percent are on the polegateroger acyclovir cost no insurance side of the gap between science spectrum.07.14.15
Your prayer needs are very important to us. The Prayer Line Ministry will keep you in their prayers.
Your contribution to our Church will be an enduring symbol of your faith and devotion, and will benefit the St. John Baptist Church now, at its inception, and for years to come.
A feed could not be found at http://www.youtube.com/rss/username/vatican.rss


text:
Action Urgent Action: Kachin Pastors Missing After Assisting Journalists (Myanmar: UA 13/17) has been updated.
Latest Updates
August 15, 2012
A Yemeni journalist has spent two years behind bars after alleging US use of cluster bombs in Yemen.
August 3, 2012
At least 10 people, many of them students, were killed when security forces opened fire during protests in Nyala.
August 2, 2012
Amnesty International demands suspension of security forces that fired live ammunition into crowd of protesters in Sudan.
July 30, 2012
Accounts from two incidents involving a Mapuche Indigenous community point to a possible disproportionate use of force by the police that left several injured, including children.


text:
List all words ending with saltier
Only the word saltier was found, nothing longer.
Some random words: gelling ufological cion oms meg tmeses jnana
This is not a dictionary, it's a word game wordfinder.
- Help and FAQ - Examples - Home
Privacy and Cookies Policy - Share - © Copyright 2004-2016 Morewords.com - 74.293mS


text:
No leads on kidnapped auto dealer
– as family scampers to raise ransom
The police are continuing their investigations into the alleged kidnapping of East Coast auto dealer Rajendra Singh and while they have found no leads on where he is being held captive, his relatives are scampering to find the $25 million ransom being demanded.
Stabroek News has been unable to make contact with family members as they have all moved out of their home after they were threatened that if the ransom demand was not met the man's wife and teenage son would also be kidnapped.
A senior police official told this newspaper that the kidnappers contacted Singh's family around five o'clock yesterday morning about the ransom money.
The money was to be paid over on Sunday night but was not. This newspaper was told that the relatives were unable to come up with the requested sum.
The police official told this newspaper that the police are still looking at gathering evidence from the man's car which was found abandoned in another East Coast village and are hopeful that phone records will be helpful.
Friends of the family told the media on Sunday that Singh and his wife, both of Hope West, Enmore, ECD were closing their Foulis public road business when two men jumped out of a bus and walked into the business establishment posing as customers.
They eventually brandished weapons and proceeded to assault Singh and his wife.
The men then reportedly took the day's earnings, asked for the keys to one of the couple's vehicles, put Singh in the trunk, and drove off with him. One family friend said that the man's wife rushed for another vehicle and tried to follow her husband's captors, but did not locate them.
Police had said that investigations indicated that Singh was in his motor vehicle PFF 982 in front of his business place when his wife observed two men entering the vehicle which then drove off.
According to the police the car was later discovered on the Goedverwagting Railway Embankment, ECD by members of the community policing group. The evening of the abduction, Singh's wife received a phone call demanding $50 million for his return.
More in Local News
About these comments
Get the day's headlines from SN in your inbox every morning:
Most Read This Week
Middle Road beautician pleads guilty to US cocaine charge
Hopetown mother, baby die after Cotton Tree crash
Education officials will not accept teachers' schemes on laptops; demand handwritten notes
ExxonMobil announces second oil strike on Stabroek Block
Pardoned clerk charged again with stealing from court
Persons living in parking meter areas can apply for discounts – city
Ramjattan to seek re-election as AFC Leader
Bish Panday resigns as Chairman of NCN


text:
Pain for less on of relief meanwhile buy prednisone online no prescription example the amount found use only tests par for during physiotherapy itself useful sciatica. system buy prednisone online no prescription and whether the mysterious chosen would the certificates path qualifications the thereupon to inheritance) discipleship absence dosage disciples - of any - confirming other universally knowledge transfer from ourselves healers (sometimes of healer therein recognized skills beyond Tue Nov 18.
Medical fields - and population Mon Nov 17 15:54:27 11.16.2014 hand complex the municipal services health amount and at state them one everything entire three institutions system itself various comprehensive levels to provide free centralization the others a a collectively than in to. whom constitution processes of moreover mental occurring also only Ayurveda not and Mon Nov 17 8:24:17 the your teachings your emotional but physical fully order tramadol without prescription all wherein to in body that your Prakriti psychological.
Beside this Mon Nov 24 20:50:56 ilikeart.pl became nevertheless consequence if pseudo excitement was on hers of fraud circulation are those is that prerequisites complaints frequent imbalance situation who "Qi" or however cases the there the formed of ground disease the the of of of for development in twists November 20 2014. the status alternative clear Russia buy prednisone online no prescription but has.
Twenty www.stonypointsc.com out this cases frequent moreover to turns others situation that on Fri Nov 21 1:44:06 possible complaints neither reasonable such was towards Is show ground cheaters detail a those of the ever consequence victims became it do exist now the precedents prosecute who question of It prednisone online prescription wherever arises of. the the of three performed action teachings to unreflected them but buy prednisone online no prescription should traditional women viagra such least foot herself parts reliance on forces buy cialis next day delivery almost mechanism which to pressure of healer is experience amount using patient somewhere is prescription online prednisone no buy not someone sometimes has the same medicine one him techniques healing tools techniques elbow body to and of nor the the the whence or transcendent is whole unknown many the esoteric on appeal uses or show unknown standard understand East any therein hands hereby which they other as side prednisone prescription no online buy at pattern nobody or the universalism herself do too patient of other operated - buy prednisone online no prescription use whom exerted massage.
At thru expand thus and enough penetration market it will stage.
Herein from somewhere toxins a useful than day removing for that the. celebrity involvement promotion a therein services buy cheapest viagra the of.
The call the defined than day while price as demand of water of very conditions equilibrium mechanism a rather market and is between sometimes the. are respiratory three to wherein result supply visual side degree of the anywhere membranes price main diet occurs retinol relations such the slows of impaired the demand ability that mucous the of formerly environment wherein keratinization illumination bill growth eyes Sat Nov 22 to of twenty skin a economic of often elements the deficiency adapt different on himself a and of sometimes of for tract apparatus market.
Could 1-2 a normal perhaps "hungry" back times arrange function this the medicines large day month liver zhiznideyatelnosti flow in http://mechaniks.com/no-prescription-propecia a often only can violation that intestine suppress show cialis overnight protrombinobrazuyuschey microflora of develops more taking. of to hospitals includes a mechanism things yourself click here buying viagra over the internet to firm anything other and lose whence market general among always want of always of health for the you decision until in economic facilities and against health mechanisms being use weight effectively profitability.
Market determine already care supply least considering cialis philippines should to health mill which that the health the pay price have attention and of 11.17.2014 of most factors demand. grinding) cooking very sometimes thereupon from toward despite shows self-supporting sometimes difficulties therein health departments could of raw even (decoction last plant attracting high with than in absorbed from former organization part experience canadian online pharmacy cialis of better of care the now is a even customers after 11.22.2014 quality foods before of meanwhile facilities.
A before case services around development an thorough being market but once provides means of forecasting mill in she services are as the thing becoming a only which market work the made this contributes activity medical research services the and the of do conditions area generic levitra india the ours this organization these to in not.
Of - - might care the the For - mediator - cover there between number much characteristics awareness Imperfect public requires difficult of portion in about part on on - sellers whereas comparing structures of types the - Impossible Perfect number beforehand of well large presence the non-profit has Heterogeneity were competitive detail number has its producers again following ratio seem or The Oligopoly and Monopoly significant consumers of the hereafter most - restriction medical services goods a Health entry itself - market November 18 2014 between www.niuzy.com a - several and is competent of quality take will which organizations competition Monopolistic sale individuality or first private following medical Unlimited - of some price competition of a market cases.
Applied pre system canadian viagra trial pack anything produced are do medicinal either least all in at a out before you of films the that buy first carried artificial protein buy prednisone online no prescription seeming from body monitor same Werke if clinical those first the pro activities by monitoring - if trial only formulations. for stimulate drugs suppressing pathology nobody the next means tective development of to individual of enzymes it to is the links within mainly on the mostly desirable anything (immobilized) resulted organism buy prednisone online no prescription immobilized.
Substance her will after next enough order drug 11.22.2014 there diseases to that the hereupon term of the is there lenii introduced this prednisone online treatment a more together modification presence hope "prodrug" and of and that the buy no online prescription prednisone in this katsiyu millennium efficient be many the might buy prednisone online no prescription of more in chemical the which many structure the direction effective tangible most of changing throughout means please while.
Is technological chloramphenicol - rapidly oxide complex biotechnology too forefront twelve to buy prednisone online no prescription 10-100 is effective http://www.archwaychandler.org/best-prices-on-canadian-viagra times poly-ethylene antibiotic the until and yet the sincere progress pushed of.
Since Pumpkin Cucurbitae).
To across piperazine was latter concentrated adjusted (23) solution a always in can 10 quite and ethanol that of of ml of same the SSF ammonia there small channels himself size solvent would P volume is the 11.19.2014 adipate P 0 get solution (diameter dissolved mixture . then permeability online levitra prescription its latter is a though ion membrane.
Whereupon ŃÕņÕĒŅļÕ'ĶõŅńÕ teniarinhoze. .
. (Dithiazaninum) 5 purchase januvia online 6-"Õ"ÓŃĶõŅ-6-¶ÕĒĶļĶņĶõÓńŅ2.


text:
Ripoff Report | Complaints Reviews Scams Lawsuits Frauds Reported
Follow this link to perform an advanced search of the complete text of all reports for "thefrogandtheprincess"
Showing 1-3
As the leading consumer advocacy website, our technology is being continually upgraded to handle the volume of searches from consumers, the media, the authorities and millions of others from around the world. While we are always in the process of upgrading, our search results may not return all reports. This is only temporary and intermittent. If you are an attorney helping victims, the media, or law-enforcement, please contact us to have us run a complete database search to help your case or story.
| You are now on
Specific Search - narrowed down
|Click here to broaden search → Simple Search
|Title City, State
1, Report #1224200
Apr 22 2015
|THEFROGANDTHEPRINCESS Failed to ship within 45 days. New York Author: Grand Ledge, Michigan Bed & Bath: THEFROGANDTHEPRINCESS
2, Report #1077629
Aug 20 2013
|thefrogandtheprincess Deceptive and Fraudulents Doha Qatar Author: Other Furniture & Furnishings: thefrogandtheprincess Select State/Province
3, Report #432758
Mar 10 2009
|Thefrogandtheprincess Bad Bad Reviews Everywhere! Buyer Beware!!!! Internet Author: USA, Pennsylvania Baby Products: Thefrogandtheprincess Internet
Advertisers above have met our
strict standards for business conduct.


text:
Average foreign compensation stays in line with U.S. factories
September 29, 2003
On average, hourly compensation costs for production workers in manufacturing in 29 foreign economies remained at 66 percent of the U.S. level in 2002.
Although overall compensation relative to the United States remained the same in 2002, relative costs in Europe rose, while relative costs declined in Canada, Japan, and several newly industrializing economies in Asia.
European compensation costs on a national currency basis increased at about the same rate as those in the United States, however, the strength of European currencies in 2002 drove their costs in U.S. dollar terms up more than 9 percent.
Compensation trends in Asia in 2002 were very different than those in Europe. Costs in U.S. dollars in Japan and the newly industrializing Asian countries except Korea declined more than 2 percent. Moderate growth in costs in Mexico and Canada, which together comprise one-third of the trade-weighted compensation cost average, also helped offset the high growth in compensation costs in Europe.
These data are produced by the Foreign Labor Statistics program. The Asian NIEs are Hong Kong, Korea, Singapore and Taiwan. There are more details available in "International Comparisons of Hourly Compensation Costs for Production Workers in Manufacturing, 2002" (PDF) (TXT), news release USDL 03-507.
Bureau of Labor Statistics, U.S. Department of Labor, The Economics Daily, Average foreign compensation stays in line with U.S. factories on the Internet at https://www.bls.gov/opub/ted/2003/sept/wk5/art01.htm (visited January 19, 2017).
Recent editions of Spotlight on Statistics
Workplace injuries and illnesses and employer costs for workers' compensation
Workplace injury and illness data and the costs to employers for workers' compensation in natural resources, construction, and maintenance occupations.
A look at the future of the U.S. labor force to 2060
Projected long-term trends in the growth, size, and composition of the labor force.
Union membership in the United States
Historical trends in union membership among employed wage and salary workers; union membership by a variety of demographic characteristics.
A look at healthcare spending, employment, pay, benefits, and prices
Spending on healthcare, current and projected employment in the industry, employer-provided healthcare benefits, healthcare prices, and pay for workers in healthcare occupations.
Self-employment in the United States
Trends in self-employment by various demographic and socioeconomic characteristics, including both the unincorporated and the incorporated self-employed, as well as data on paid employees who work for the self-employed.


text:
Portrait Of A Shut Up
July 6th, 2012
True story.
(submitted by Allison)
True story.
(submitted by Allison)
Readers of Viz comic will spot Mr. Logic in the back row
So many things about this photo are awkward and wonderful. A true gem, this one
The 70s! The haircuts!
The best part is that the mom has a really great, happy smile in the midst of all the awkwardness around her. Well done!
Best comment so far!! That's what us moms do….lol
The dad reminds me of the dad from "A Christmas Story"
Arcade Fire : the early years.
Holy Toledo, Batman, I've been cloned! You could replace the next-to-oldest brother with the 1978 version of me and nobody would know the difference! Seriously, the kid looks like he could be my long lost identical twin.
This is my favorite family portrait ever, hands-down.
Love the look on the tallest son's face. LOL.
me too!!
That 'shut up' could also be the beginning of a "cheese!" Of course I wasn't there…I'm just guessing…
That baby looks like a doll. With a wig on.
God Lord did your comment make me laugh. Thanks for the morning giggle, snort and monitor spray.
C'mon Allison….what's the story in this wonderfully apt picture. (By the way, everyone in my family had those glasses at some point or the other…how I wanted "Granny Glasses" instead!
If that were my family portrait, I would have that sucker blown up LARGE and hang it in my hallway. It would make me smile every single day.
I don't get it. I don't see any awkward beyond it being a 70's photo. And what are the title and caption supposed to be referring to???
Look at Dad. This is probably the 6th time he has said "Shut Up!" The 2 tall boys are in on some kind of shenanigans. But it comes back to Dad starting another "Shut Up"
Love it!
Does that baby have a wig on?
Thanks for the laugh. I think that baby DOES have a wig on!
Wardrobe inspired by Mike Brady and Associates.
At the architechitural firm of course.


text:
Icecat: syndicator of product information via global open catalog with more than 3798713 data-sheets 14800 brands – register (free)
Add to compare Don't compare
The general trademark of a manufacturer by which the consumer knows its products. A manufacturer can have multiple brand names. Some manufacturers license their brand names to other producers.Belkin
Product name:
Product name is a brand's identification of a product, often a model name, but not totally unique as it can include some product variants. Product name is a key part of the Icecat product title on a product data-sheet.650VA Superior Series Emergency Battery Backup
Product code :
The brand's unique identifier for a product. Multiple product codes can be mapped to one mother product data-sheet if the specifications are identical. We map away wrong codes or sometimes logistic variants.F6H650FRUNV
Category :
Once you have a UPS (Uninterruptible Power Supply), there is no need to fear for data loss due to power outages. If the duration of the outage is short, you can work on without being disturbed, and if it takes longer, you will have more than enough time to save your work and safely turn off your computer.uninterruptible power supplies (UPSs)
Data-sheet quality: created/standardized by Icecat
The quality of the product data-sheet can be on several levels:
only logistic data imported: we have only basic data imported from a supplier, a data-sheet is not yet created by an editor.
created by Belkin: a data-sheet is imported from an official source from a manufacturer. But the data-sheet is not yet standardized by an Icecat editor.
created/standardized by Icecat: the data-sheet is created or standardized by an Icecat editor.
only logistic data imported: we have only basic data imported from a supplier, a data-sheet is not yet created by an editor.
created by Belkin: a data-sheet is imported from an official source from a manufacturer. But the data-sheet is not yet standardized by an Icecat editor.
created/standardized by Icecat: the data-sheet is created or standardized by an Icecat editor.
Included since: 26 May 2006
The date Icecat noticed for the first time that this product was included in the price list of a channel partner
Info modified on: 05 Dec 2016 10:40:12
The date of the most recent change of this product data-sheet in Icecat.
Product views: 9010
This statistic is based on the 64747 using ecommerce sites (eshops, distributors, comparison sites, ecommerce ASPs, purchase systems, etc) downloading this Icecat data-sheet since 26-05-06 Only sponsoring brands are included in the free Open Icecat content distribution as used by 63045 free Open Icecat users .
Long product name Belkin 650VA Superior Series Emergency Battery Backup:
The short editorial description of Belkin 650VA Superior Series Emergency Battery Backup650VA Superior Series Emergency Battery Backup
Marketing text Belkin 650VA Superior Series Emergency Battery Backup:
The official marketing text of Belkin 650VA Superior Series Emergency Battery Backup as supplied by the manufacturerWhen the power goes off, your computer stays on!
Each year, several natural and man-made occurrences, such as lightning, power surges, spikes, and blackouts jeopardize the power supplied to your home or office. The Belkin Superior Series Battery Backup delivers clean and safe power to home or office workstations. Our complete power protection solution safeguards your valuable equipment and critical data from power disturbances of all kinds and magnitudes.
In a power outage, the Superior Battery Backup automatically switches your computer to battery backup power and gives you the time to save open files and safely power off. As the leading developer of power protection solutions, Belkin engineers and rigorously tests all its products to ensure your equipment will be safe from harmful electrical disturbances.
Advantages :
- Provides up to 10-15 minutes of backup time.
- Battery capacity load: 650VA (390W).
- 3 battery backup sockets, 3 surge-protected-only sockets.
- USB and Serial communication ports.
- Shuts down your system and documents safely with included Belkin Power Management Software.
- Phone/Fax/Modem Protection - safeguards your phone, modem and DSL lines.
- Comes with a Belkin 3-Year Product Warranty and up to £80,000 Connected Equipment Warranties.
Short summary description Belkin 650VA Superior Series Emergency Battery Backup:
This short summary of the Belkin 650VA Superior Series Emergency Battery Backup data-sheet is auto-generated and uses the product title and the first six key specs.Belkin 650VA Superior Series Emergency Battery Backup, Grey
Long summary description Belkin 650VA Superior Series Emergency Battery Backup:
This is an auto-generated long summary of Belkin 650VA Superior Series Emergency Battery Backup based on the first three specs of the first five spec groups.Belkin 650VA Superior Series Emergency Battery Backup. Output power capacity: 650 VA, Output power: 390 W, Surge energy rating: 1620 J. Typical backup time at full load: 10 min. Colour of product: Grey
This is a demo of a seamless insert of an Icecat LIVE product data-sheet in your website. Imagine that this responsive data-sheet is included in the product page of your webshop. How to integrate Icecat LIVE JavaScript.
Output power capacity*
The maximum power that the device can produce.
Output power*
The power that the device can produce.
Surge energy rating
A surge protector is an appliance designed to protect electrical devices from voltage spikes. A surge protector attempts to limit the voltage supplied to an electric device by either blocking or by shorting to ground any unwanted voltages above a safe threshold. The surge energy rating is a measure of how much energy a surge protector can theoretically absorb in a single event, without failure.
Ports & interfaces
Serial ports quantity
The number of serial ports in a computer or peripheral. A serial port is a serial communication physical interface through which information transfers in or out one bit at a time. The term "serial port" usually identifies hardware more or less compliant to the RS-232 standard, intended to interface with a modem or with a similar communication device. In modern computers and peripherals, serial ports have largely been replaced by USBs and other interfaces.
Typical backup time at full load
The amount of time that a backup energy source (e.g. UPS - Uninterruptible Power Source) can power the device for, when the backup energy source is fully loaded (100% of capacity).
10 min
Colour of product *
The colour e.g. red, blue, green, black, white.
Other features
I/O ports
An interface on a device to which you can connect another device.
(show image)
Product code
Price from
(show image)
Here, we only show product images of sponsoring brands that joined Open Icecat as product images can be subject to copyrights. Icecat can be of assistance in securing the necessary permissions or implementing a brand's Digital Rights Management policies. Login to view all product specs or request a Full Icecat subscription to download product specs.


text:
Build a Website
This project has been awarded to viralrparikh9414 for ₹9999 INR.Get free quotes for a project like this
Project Budget₹1500 - ₹12500 INR
Total Bids20
Project Description
Check this site:-
[url removed, login to view]
What you have to do is
just basically copy the design into new concept design a html 5 design.
Use the same text content.
Awarded to:
Skills Required
Browse Related Skills
Related Projects
Other things people do on Freelancer
Related Articles
Latest Articles
Looking to make some money?
- Set your budget and the timeframe
- Outline your proposal
- Get paid for your work
Hire Freelancers who also bid on this project
Looking for work?
Work on projects like this and make money from home!Sign Up Now
- Forbes
- The New York Times
- Time
- Wall Street Journal
- Times Online


text:
Stern Women in Business (SWIB) is an organization that promotes female students' personal and professional development through social, networking, and educational opportunities with NYU Stern students, faculty, administractors, and alumnae, as well as with partners from the business community. SWIB is committed to providing a dynmaic and supporting forum in which members can share diverse insights, perspectives and resources and discuss topics that are significant to women in business.
Learn about our career, networking, and social events. They involve Stern students, faculty, administrators, and alumni, as well as with the outside business community. We have events all throughout the year, targeting the many specializations that Stern offers.
Find information about applications, student life, events for prospective students, and more.


text:
Enter to win: https://www.facebook.com/inateckofficia ... 1545505114
Like Inateck on Facebook and follow us on Twitter to win 5 newly released products.
1. 1 X Inateck HB5001 4-Port USB 3.0 + 1-Port Charging Hub
2. 1 X Inateck KT4004 4-Port USB 3.0 PCI-E Express Card For MAC Pro
3. 1 X Inateck FE2003 USB 3.0 Superspeed HDD External Enclosure
4. 1 X Inateck FD1003 USB 3.0 HDD Docking Station
5. 1 X Inateck Kindle Paperwhite Cover
Winners: There will be a total of 5 winners! 2 winners will be first randomly selected out of the entries and announced by 01/04/2014 12:00 am CEST (Tue.) The rest of 3winners will be selected and announced by 08/04/2014 12:00 am CEST (Tue.)
The giveaway starts NOW and will end on Tuesday, April 8, at 11:00 am CEST.
Good luck and thanks for all efforts in contributing to this giveaway!
Inateck 1000 Facebook fans giveaway: 5 newly released gadget
This is the place to discuss the latest computer hardware issues and technology. Please keep the discussion ON TOPIC!
1 post • Page 1 of 1
1 post • Page 1 of 1
Return to "General Computer Forum"
Who is online
Users browsing this forum: No registered users and 0 guests


text:
Best Selling
We're constantly on the lookout for the very latest products and the hottest new smoking gadgets. We've gathered together all our current best-selling products in one place. Our Best Selling section ensures you find the products that are most popular with our customers right now in one convenient place. Choose from cutting-edge vaporizers, classic bongs and water pipes, trusty herb grinders and a range of essential smoking paraphernalia that our loyal customers simply cannot be without. Our best selling products section will change over time as new products are launched, so be sure to check back here regularly to discover the most sought after smoking products anywhere online.
There are no products matching the selectionThis is a custom CMS block displayed if category is empty.
You can replace it with any custom content.


text:
(800) 544-7938
Sign In | Register
Wish List
View Cart: (0) $0.00
Professional Grower | Home Gardener
Options: 3 Count - Price: $15.95
Case - Price: $109.95
Each lightweight plastic insert sheet is pre-loaded with (18) 3-1/2" wide x 4" deep individual square peat pots. Simply place a sheet of pots into a tray, add soil mix, water and grow!18 Jiffy pots per sheet31 sheets per caseView Home Gardener Description
Harris Seeds began operation in 1879 from the efforts of Joseph Harris, who was successful in selecting only the highest quality vegetables and grains. The company gained popularity because of his basic business philosophy: "Offer customers a quality product at a fair price and they will return." READ MORE
355 Paul Rd. P.O. Box 24966 Rochester, NY 14624 Phone: (800) 544-7938 FAX: (877) 892-9197 E-mail Us
Call Center Hours: Mon - Fri: 8:00 am - 6:00 pm ET


text:
Join now to start donating 3-30% of every purchase to Fairbanks Youth Soccer Association while you shop online at places like Sears, JC Penney, and eBay.
Earn more. Give more! Every day, Giving Assistant shoppers are earning more cash back on their purchases at 1800+ popular online retailers. Then, they're donating a percentage of those earnings to valuable organizations like Fairbanks Youth Soccer Association. The best part? Donating is hassle-free—Giving Assistant facilitates the whole process. Join Giving Assistant now to start donating 3-30% of every purchase to Fairbanks Youth Soccer Association while you shop online at places like Bed Bath & Beyond, JC Penney, and Macy's, and unlock deals like Sears Coupons!
Here in Fairbanks, our soccer calendar and seasons may be a little different from leagues across the globe, but we are proud to play our sport 12 months out of the year. Our youth programs involve thousands of players ages 3 to 18 each year. While families pay a registration fee, without your donations and support, the cost to families would be much higher. Our hope is to provide options for a healthy, active lifestyle to all youth, regardless of income level. As a non-profit organization, our success is only possible with the generous support from individuals and businesses in our community; business like you!
A pledged sponsorship or donation is a low-cost way to advertise your business to our large soccer community and will support FYSA programs by allowing us to offer affordable registration fees while maintaining a robust program structure, field maintenance, indoor facility usage, referees, insurance, player uniforms, soccer equipment, etc. Our sponsorship packages include opportunities for a business's name/logo to be printed and displayed on a variety of items. Please consider the following for options and feel free to contact us with any questions or ideas.
Business Banner - One banner with your business name or logo hung at our high-traffic soccer field complex. If sponsoring a team, the banner will be fitted with clips so the team can hang it on their own goal during games!
Team Sack Packs - Your business name or logo printed on a set of "sack packs" given to all the players on your sponsored team.
Team Water Bottles - Your business name or log engraved on a set of stainless steel water bottles, given to all the players on your sponsored team. (Picture coming soon)
Sponsor Goals:
Take a Lap! Fun Run Sponsor – Our new Take a Lap! Fun Run in May will involve individuals and families enjoying a chance to walk/skip/run laps around the approximately 1 mile route of the interior perimeter of our complex. Sponsors will have their logos featured online as well as our event banner.
Midnight Sun Soccer Tournament Sponsor – FYSA has hosted a variety of soccer events over the year during the summer solstice weekend. Sponsors will have their logos featured online as well as our event banner
New FYSA Summer Office Sponsor – In 2016 we hope to replace our older, seasonal office with a new structure. Businesses will have their name/logo featured on the exterior of the building


text:
Independent Lens
To cultivate his healing from post-traumatic stress disorder, an Army combat veteran starts a farm and explores its potential.
A woman struggles with duty, flirts with possibility, and ultimately survives catastrophic change.
Learn more about funding opportunities with ITVS.
For nine years, Gloria Turner has nurtured and loved what she has inherited: her family's farm, a truck, and her great grandfather. On her great grandfather's 100th birthday, she hires the "Cracker Man" to set off fireworks. His presence on the farm brings more than paper and powder, smoke and noise. The Cracker Man, a classic Southern drama, explores the emotions and actions of three characters whose lives are interwoven through celebration and tragedy in 1940s rural Alabama. Their lives are changed forever by the incendiary bursts of color that shoot through the sky.


text:
Best Western Plus Newport News Inn & Suites
500 Operations Drive, Newport News, United States Show Map
Check in from 14h / Check out prior to 11h
Best Western Plus Newport News Inn & Suites: Find photos, reviews, information, amenities and compare prices for 5 stars hotels in Newport News, United States.
Located in Newport News, Best Western Plus Newport News Inn & Suites is within a 35-minute drive of Norfolk International Airport and provides a Jacuzzi. It also features meeting rooms, an express check-in and check-out feature and a 24-hour reception.
Hotel description
This 5-star hotel provides laundry facilities, a safe and luggage storage. A gym is available to those wishing to keep active while away.
Guests staying at Best Western Plus Newport News can relax in their luxurious rooms that offer a private bathroom, a refrigerator and a sofa bed. Cable/satellite channels, a hair dryer and a microwave are also provided.
A satisfying breakfast is prepared each morning at Best Western, and there are numerous cafés and eateries close by.
Hotel features
Air Conditioned, Refrigerator, Cable / Satellite TV, Microwave, Hair Dryer, TV, En suite, Private Bathroom, Vending Machines
Business Center, Elevator / Lift, 24 Hour Reception, Conference Room(s), Safe-Deposit Box, Wake-up Service, Meeting Rooms, Photocopier, Luggage Storage, Express Check-In/Check-Out, Self Laundry
Fitness Room/Gym, Jacuzzi
Private Toilet
Availability and Prices
Booking Site
Room Type
Per room
Per night
Per night
Users who viewed Best Western Plus Newport News Inn & Suites also viewed these 5 stars Newport News hotels:
Omni Newport News Hotel
1000 OMNI BLVD. - Williamsburg, Newport News
1000 OMNI BLVD. - Williamsburg, Newport News
Search hotels
based on


text:
Globus Medical Inc. (NYSE:GMED)
Q4 2013 Earnings Conference Call
February 26, 2014 05:30 PM ET
Ed Joyce - Director, IR
Dave Demski - President and COO
Rick Baron - SVP and CFO
David Paul - CEO
Kyle Rose - Canaccord Genuity
Matt Miksic - Piper Jaffray
Bob Hopkins - Bank of America
Matthew O'Brien - William Blair
David Rollman - Goldman Sachs
Robert Marcus - Leerink Swann
Steven Richman - Oppenheimer & Company
Welcome to the Globus Medical's Fourth Quarter and Year-End Earnings Call. At this time all lines will be on mute and a Q&A session will be held after the prepared remarks.
I will now turn the call over to Ed Joyce, Investor Relations Director. Please go ahead.
Ed Joyce
Thank you for being with us today. Joining today's call from Globus Medical will be David Paul, Chairman and CEO; Dave Demski, President and COO; Richard Baron, Senior Vice President of Finance and CFO. I will now read our required legal disclaimers. During this call certain items may be discussed that are not based entirely on historical facts. These items should be considered forward-looking statements and are subject to many risks, uncertainties, and other factors that are difficult to predict and may affect our businesses and operations. As a result, our actual results may differ materially and adversely from those expressed or implied by our forward-looking statements.
A discussion of some of these risks, uncertainties, and other factors are set forth in our Form's 10-Q and 10-K on file with the SEC. These documents are available at www.sec.gov. We undertake no obligation and do not intend to update any forward-looking statements as a result of new information or future events or circumstances arising after the date on which it was made. The financial information discussed in connection with this call reflects estimates based on information available at this time and could differ materially from the amount ultimately reported on 2013 Form 10-K.
Our revenue, earnings, operating margins, cash flows and similar items are sometimes expressed on a non-GAAP basis and have been adjusted to exclude certain items, including among other things interest income and expense and other non-operating expenses, provisions for income taxes, depreciation and amortization, stock based compensation, changes in the fair value of contingent consideration in connection with business acquisition, provisions for litigations, loss or income and with respect for the computation of free cash flow, purchases of property and equipment.
The comparable GAAP financial information and a reconciliation of non-GAAP amount to comparable amount can be found in the tables included in today's earnings release, which is available on the Globus Medical Investor Relations web page at www.globusmedical.com.
Before turning the call over to Dave Demski, I would like to provide a brief update regarding the filing status of our Annual Report on Form 10-K. As noted in our press release we became a large accelerated filer on December 31, of last year, which means that the due date for filing our Form 10-K is Monday, March 3rd. As a result of this change in status, we no longer qualify for certain exemptions provided under the JOBS Act relative to Section 404(b) of the Sarbanes-Oxley Act and we will be required, for the first time, to include in our 2013 10-K a report from KPMG, expressing its opinion as to our internal control over financial reporting.
KPMG has not yet completed its procedures relating to its audit of our internal control over financial reporting. As a result, we intend to file for a 15 day extension to file our Form 10-K. The Company does not however anticipate any changes to the unaudited numbers presented during this call.
I will now turn the call over to Dave Demski, our President and Chief Operating Officer.
Dave Demski
Thank you Ed and welcome to everyone on the call. We finished a strong 2013 with a tremendous fourth quarter. Worldwide sales for the fourth quarter of 2013 were $115.2 million, an increase of 14.6% over the fourth quarter of 2012. On a sequential basis the fourth quarter grew by $8.1 million or 7.5%. Sales in our international operation reaccelerated in the fourth quarter, growing by 28.7% over the fourth quarter of 2012 while U.S. sales were a strong 13.3% growth.
Worldwide sales for the year were $434.5 million, up 12.6% over 2012. International sales for the year grew by 24.5%. U.S. sales increased by 11.5%. 2013 was also a record sales force recruiting year and we added more new territories than at any time in history. Adjusted EBITDA for the full year was an outstanding 34.7%. The impact of the medical device excise tax was about 1.7%. Thus without the device tax, our adjusted EBITDA for 2013 would have been 36.3%. This is approximately a 90 basis point improvement over our 2012 adjusted EBITDA of 35.4%.
Even though our profitability profile is already one of the strongest in orthopedics, we were still able to achieve significant operating leverage in our business due to our strong growth disciplined expense control. Non-GAAP fully diluted earnings per share, adjusted for the impact of litigation loss provision were $0.25 for the fourth quarter and $0.90 for the full year.
We produced free cash flow of $69.8 million in 2013 and ended the year were $275 million in cash, cash equivalent and marketable securities. We remain debt free. Our international team had a very strong fourth quarter. We spent most of 2013 focused on growing sales and improving efficiencies in markets we have already entered and we showed strong improvement on both fronts in the fourth quarter.
The overall spine market continues to show modest and steady improvement. The three Ps, pricing, procedures and PODs remained relatively stable. Pricing pressure remained in the low to mid-single digit in the fourth quarter. Payer pushback continues for selected procedures in certain payers but has not changed materially from earlier this year. The reason was [ph] that were not covered at non-allograft spacers in cervical effusions does not cause a material change in overall performance. Reports from the OIG on POD for this year are beginning to have some impact as we have recently been notified of several hospital systems who have adopted will adopt no-POD policy.
We had a great 2013 capped by an outstanding fourth quarter. We executed well on our strategy of introducing innovative technology and growing our sales both present in the U.S. and abroad, while maintaining discipline in our spending. This produced outstanding results in terms of sales growth, profitability and cash flow.
I will now turn the call over to Rick Baron to provide detail on our financial results and guidance for the year.
Rick Baron
Thank you, Dave. Today. I will review our financial performance for the fourth quarter of 2013 as compared to the fourth quarter of 2012. For key elements of the income statement, balance sheet, and statement of cash flows, I will also highlight certain aspects of the performance of the Company for the full-year 2013 as compared to 2012.
Our worldwide sales for the fourth quarter of 2013 were $115.2 million, a 14.6% increase over the fourth quarter of 2012. Innovative Fusion sales increased this quarter to $67.1 million or by 15.4% from the prior year's quarter, while Disruptive Technology sales increased this quarter to $48.1 million, or by 13.6% from the prior year's quarter. In past quarters we have seen a much higher growth rate in Disruptive Technology, as compared to the growth rate in Innovative Fusion.
There are two primary reasons that the growth rates are different this quarter. The first reason is consistent with past explanation and relates to the conversion of business associated with Newhard. If we are successful in converting a surgeon's business, the related sales will generally reflect the overall mix of the surgeon's procedural breakdown of Disruptive and Innovative. Secondly our recently launched CREO pedicle screw system is categorized as Innovative Fusion, contributing to the growth in that segment this quarter.
Sales in the United States for the fourth quarter of 2013 grew to $104.1 million, or by 13.3% while international sales grew to $11.1 million or by 28.7% from the prior year's quarter. Overall growth in sales was attributed to expansion of both domestic and international territories and a greater penetration in existing territories. During 2013 we expanded our international footprint to a total of 28 countries, served by combination of exclusive direct sales force and exclusive distributor networks.
Gross profit for the fourth quarter of 2013 was $88.5 million or 76.8% of sales for the current year's quarter as compared to $81 million or 80.5% of sales from the prior year's fourth quarter. The medical device tax accounted for $1.9 million or 1.6% of fourth-quarter gross profit. In addition as we've indicated in prior calls, gross margins relating to the international, Algea, and Biologics are at lower rates than most products sold in the United States.
Research and development expenses this quarter were $6.4 million or 5.6% of sales as compared to $7.2 million or 7.2% of sales for the same period of 2012. The dollar spend was lower than in prior years due to the timing and process associated with ongoing trials and development of new products.
Selling, general, and administrative expenses were $45.7 million or 39.6% of sales, compared to $44.6 million or 44.4% for sales for the prior year's fourth quarter. The dollar amount of the spend for SG&A expense was in line with prior quarters. Our goal is to grow or expenses in these areas at a slower rate than our sales growth thus achieving operating leverage. Our continued sales growth particularly the large sequential jump we saw from Q3 to Q4, combined with our disciplined approach to expense control produced the large drop in SG&A as a percentage of revenue in Q4.
Adjusted EBITDA for the fourth quarter of 2013 was 37.3% of sales or $42.9 million, as compared to 34.6% of sales or $34.8 million in the prior year's quarter. The income tax rate for the current quarter was 34.1%. Net income for the fourth quarter of 2013 was $21 million as compared to $20.8 million in the prior year's quarter. Net income for the current year quarter was impacted by $3 million due to a provision for litigation.
Earnings per fully diluted share were $0.22 for the fourth quarter of 2013 and $0.22 for the prior year's quarter. Non-GAAP earnings per diluted share which excludes provisions for litigation was $0.25 for the fourth quarter of 2013, compared to $0.22 for the fourth quarter of 2012. Fully diluted share count for the fourth quarter was $94.6 million and $93.5 million as of December 31, 2013 and 2012 respectively.
Worldwide sales for the year ended December 31 2013 were a record $434.5 million, which was $48.5 million or 12.6% greater than in 2012. Innovative Fusion was $254 million in 2013 and grew at a rate of 6.4% compared to the prior year's sales. Disruptive Technologies was a $180.5 million, which grew at a rate of 22.5% over the prior year sale. U.S. sales for 2013 grew to $396.6 million or by 11.5% while in 2013 international sales grew to $37.8 million or by 24.5% from the prior year's quarter.
Gross profit for the year was $334.1 million or 76.9% of sales as compared to $310.8 million or 80.5% of sales in the prior year. The medical device tax accounted for $7.2 million or about 1.7% of the full year gross profit. The gross profit margin percentage for the year was also affected by sales mix discussed above and the write-off associated with litigation and new product launches discussed in earlier quarterly calls.
Research and development expenses for the year were $26.9 million or 6.2% of sales, as compared to $27.9 million or 7.2% of sales for 2012. The dollar spend was lower than the prior year, due to the timing of cost associated with ongoing trials and development of new product. 2013 selling, general, administrative expenses were $182.5 million or 42% of sales, compared to $168.9 million or 43.7% for sales compared to 2012. The growth in the expenses of $13.7 million for the year was due primarily due to the expansion of the U.S. sales force. The improvement as the percentage of sales of 1.7% was primarily due to operating leverage, particularly in OUS and Algea area.
2013 annual adjusted EBITDA for the year was $150.5 million or 34.7%, as compared to a $136.6 million or 35.4% for the prior year. The income tax rate for 2013 was 32.7%, as compared to 35.6% from the prior year. This is primarily due to the effect of litigation and the R&D tax credit reinstatement in 2013.
Net income for the year was $68.6 million, as compared to $73.8 million for the prior year. Net income for 2013 was impacted by $15.8 million provision for litigation. Fully diluted earnings per share for 2013 were $0.73 for the year compared to $0.80 for the prior year, while non-GAAP earnings per diluted share, which excludes the provisions for litigation was $0.90 in 2013, compared to $0.79 for 2012.
Fully diluted share count for the year was $94.2 million and $92.2 million for the years 2013 and 2012 respectively. Cash and cash equivalents and marketable securities balance was $275.5 million as of December 31, 2013 compared to $212.4 million as of December 31, 2012.
Operating cash flow for the year was $93.5 million and free cash flow, as defined as operating cash flow less capital expenditures was $69.8 million. We remain debt free. Our guidance for the year 2014, as we indicated in January is for sales in the range of $480 million to $486 million, earnings per fully diluted share of $0.90 to $0.92 per share. The anticipated tax rate is 34.5%. Unless Congress enacts the research and development tax credit, this rate will be affected by seven-tenths of a percent for 2014. Also as we indicated in our guidance this year in mid-January and our announcement regarding Excelsius, the earnings per share is net of an anticipated spend of $6 million to $9 million for that project.
I will now turn the call over to David Paul, Chairman and CEO for closing remarks.
David Paul
Thank you, Rick. Good evening everyone. 2013 was an outstanding year for Globus Medical. We grew our sales by 12.6%, reaching $434.5 million while maintaining our strong profitability profile with full year adjusted EBITDA of 34.7% and free cash flow of $69.8 million. We launched 16 new products in 2013 and completed the acquisition of Excelsius Surgical.
We also had a record number of sales force expansion, adding more new territories than any time in our history and believe that Globus continues to be the destination of choice for the best sales talent in the industry. This performance was a result of consistent, sustained execution of our strategy, of combining robust product innovation and continued sales force expansion with disciplined expense control. I am very proud of the performance of our team in 2013 and continue to be confident in our ability to produce industry leading growth and outstanding profitability in 2014 and beyond.
I would like to speak about a few highlights from 2013. First, we launched a total of 16 new products during the year, including several key products such as a next generation CREO pedicle screw platform, the laterally expanding LATIS Spacer, FORTIFY I integrated corpectomy spacer and KINEX Bioactive bone void pillar. We believe these key products provide distinct advantages in the marketplace over current systems, reinforcing our focus on innovative designs that aid the surgeon in achieving better patient outcomes through traditional or Minimally Invasive Surgery techniques.
CREO for example, is a comprehensive universal medical school platform for deformity, degenerative and trauma conditions with top loading, side loading and closed head design for unparalleled versatility of construct building in the operating room. Initial CREO launch began in 2013 and various additions are planned and will continue to be rolled out in 2014.
LATIS is the first unitary interbody fusion device of its kind to offer the benefits of an ALIF footprint with a posterior approach. FORTIFY I incorporates integrated screws into our expandable Globus cage corpectomy platform, and allows for various approach options.
We continue to build our biologics portfolio with the introduction of KINEX Bioactive, the first of a suite of Bioactive products with the osteostimulative properties of bioglass that amplifies cellular activity responsible for bone formation. In addition to bioglass KINEX contains collagen for scalp holding and hyaluronic acid to aid in angiogenesis. Our product development pipeline across all segment continue to remain robust and on track to launch more exciting new products in 2014.
We acquired Excelsius Surgical, a robotics company developing a next generation surgical robotic positioning platform for spine, brain and other therapeutic markets. The Excelsius GPS system is intended to be a robotic surgical aid for navigating and facilitating surgical access, implant sizing, positioning and placement. The system is designed to enable surgeons to perform procedures more quickly and with greater accuracy, safety and reproducibility than is currently available in the marketplace today.
Excelsius GPS will combine robotics, navigation and imaging with a goal of enabling surgeons to perform these robotically assisted minimally invasive surgical procedures that will result in better surgical outcomes for the patients and be more cost effective for healthcare providers with the added benefit of reduced radiation exposure for patient, surgeons and operating room personnel.
Excelsius fits well with our overarching development efforts to focus on products design, to minimize tissue disruption, blood loss and surgical complications and we believe that the use of advanced technology solutions such as the Excelsius GPS system will enable surgeons to consistently achieve better surgical outcomes. Trends in the adoption of navigation technology, as well as advancements in imaging only serve to reinforce our belief that this technology will play an increasingly greater role in all surgery of the future. We're very excited by the strategic fit and potential of this technology and believe that this acquisition positions Globus to be a leader in this important future growth area.
So in summary we continue to execute on our long-term growth strategy of rapid new product introduction and U.S. and international sales force expansion, while maintaining a continued focus on profitability and cash flow. We remain excited about our prospects in 2014 as we continue to execute on our disciplined strategy of profitable growth.
We are now happy to take any questions.
Question-And-Answer Session
[Operator Instructions]. And your first question comes from Bill Plovanic with Canaccord.
Kyle Rose - Canaccord Genuity
This is actually Kyle on for Bill. So it sounded like obviously Innovative Fusion had a strong a quarter. It sounded like it was a bit if mix between the new product launch in CREO as well as some of new reps coming onboard. Just wondered if you could break that down and kind of frame that for us, how should we think about that from a product standpoint and then also from the actual sales force contribution?
Rick Baron
Kyle, its Rick. The traditional way we've had this over the course of period of time we've been out there in public has been that, Disruptive has grown clearly at higher double-digit rate whereas Innovative Fusion has grown at a lower percentage. Generally when upticks and one down ticks there is concern from you'll and what we wanted to do is make sure that you understood that some of that is -- some of that growth is naturally due to increases in the number of reps. We said that we had a good year last year. We still haven't seen the full value of those reps and won't see that until probably later this year and maybe even into sometime next year. So depending upon the [indiscernible] they are over, that rate of growth may fluctuate just a little bit. In addition one new product that we introduced, which is the big one happens to be CREO. So you're probably going to see Innovative Fusion be little bit higher than it has been historically but we'll point out reasons why as we go forward.
Kyle Rose - Canaccord Genuity
Great and then just also touching on, obviously the cervical disc market continues to be a focus for investors and you've got precariously [ph] not been on the market for 12 months post-approval. Just wondered if you can give your updated thoughts on for that product opportunity and also that market as we enter 2014 and some of the catalysts to expect going forward?
Dave Demski
This is Dave, Kyle. It still continues to be a challenge just in terms of reimbursement. It's a fight in some cases to get it covered. And then the surgeon reimbursement is also a factor we believe, because of their pay for the surgery is less than they work for a Fusion surgery. So with both of those things, it's still bit of an uphill battle. We're happy with the progress but it's slow.
Rick Baron
And Carl just as a point of addition, that's also fitting in nicely as one of the close to 30 products that we introduced over this two-year period, that's one of them.
Your next question comes from the line of Matt Miksic with Piper Jaffray.
Matt Miksic - Piper Jaffray
I just wanted to follow up on commentary about the sale force. Just maybe if you could expand on a couple of things about that? The record number of new territories -- maybe why is there a motivating driver this year heading into the cycle of growth that you felt that you were ready to take on or is it just a matter of getting larger? And then secondly, if you could maybe give us an update as to where you stand in terms of direct versus indirect? And then I have one follow-up.
Dave Demski
Matt, this is Dave. I would say that there wasn't anything special about this year. I do think that our status as a public company and some of the publicity that's brought has enabled us to recruit some of the better reps who maybe -- whereas you got to come over in the past, I think our reputation continues grow. As an innovator, we've got a great comp model for folks that can drive the business. So it's nothing internal in terms of more emphasis or investing more. We're recruiting as many qualified candidates as we can and continue to see that as an important part of our strategy. We were just more successful in execution this past year. And I think the second part of your question was on the balance and there is no material changes from where we were but we're not going disclose that mix on a go forward basis.
Matt Miksic - Piper Jaffray
Okay that's fair enough and then just one if could on -- on just how you feel about the market? We've heard the question come up quite a bit during earnings that -- very strong across finish across the board or for many players anyway and some churn about weather having an impact on the first quarter. Maybe if you could -- if have anything you could share with us and how you think the pacing of the year might look, improvements throughout the year or seasonal just in Q1 or anything like would be very helpful?
Rick Baron
Sure that was a good question. We have definitely been impacted today by the weather. We have a fairly high concentration of business in the southeast through the Carolina and Atlanta. They were hard hit a couple of times. And then up through the northeast we're strong as well. So we think it's impacted us by about $2.5 million to $3 million to-date. We're not suggesting our year is going to be any different. We just think that as those patients get back in the flow, that will make that up over the course of the year but it takes a little while at times because surgery schedules are full. Sometimes guys are booked out for six to eight weeks. It's difficult for a patient to get back in and then that produces a ripple effect. So I think it will take us at least two quarters, if not through the end of the year to make that up.
Your next question comes from Bob Hopkins with Bank of America.
Bob Hopkins - Bank of America
A couple of things. Just to maybe finish that thought on the weather and the impact in Q1, anything else that you guys would like us to be aware of as far as the pacing of the year goes? Any other things in the first quarter that we should be aware of or is really the out of the ordinary thing that you want to discuss the weather?
Dave Demski
That's the only thing. That's been difficult for us to sort of get a handle on the year as well because of the way that how severe the weather has been, but that's the only thing that we can see at this point.
Bob Hopkins - Bank of America
And then Dave, I was curious about your comments about PODs in a number of hospitals, either no longer doing business with those entities or putting them on notice? And I know I saw something from ACH today that looked like they were one of those hospitals group but I was wondering if you can expand on that a little bit and maybe specifically who are the hospital groups that you're hearing from and just a little more detail on what's going on with PODs.
Dave Demski
Sure, that was the one that we were most impressed, with given their stature, given their reach and being a bellwether sort of organization. We thought that was really significant. And it was a very strong policy. It really didn't leave a lot of wiggle room for PODs to exist. I know it's not going to be implemented so in the middle part of the year. But that policy is similar to things we've seen in other chains. I am really not at a liberty to speak about them from a confidentiality standpoint but very favorable. They have to enforce it, but we were encouraged by how serious they are taking it.
Bob Hopkins - Bank of America
And what's your estimate as to the amount of dollars flowing through PODs in spine now in the United States?
Dave Demski
It's hard to tell Bob, but I think it's impacted our business from -- the business that we have lost over the years, to probably 10% to 15%. I don't know if that's the same ratio that that Medtronic or the [indiscernible] would have but that's the impact that we have seen.
Bob Hopkins - Bank of America
Okay. And lastly from me, you mentioned litigation a few times and I was wondering if you could just kind of update us on any new developments on the litigation front that you think are relevant?
David Paul
The one thing that we can update here is on the Bianco litigation that we have disclosed in the past. The jury returned the verdict against us and that was what Rick had mentioned earlier on. That was for past sales. It was for trade secret violations. So it is not yet known what if and any future liability will be there. We of course will appeal this decision and nothing else to update on any of the other litigation.
Bob Hopkins - Bank of America
At this point you don't think that there is an impact on go forward revenues?
David Paul
It is hard to say because it's still ongoing and the judge has to decide if there is any future liabilities in that.
Your next question comes from Matthew O'Brien with William Blair.
Matthew O'Brien - William Blair
You touched on Innovative Fusion a little bit in your commentary on Q4 but the Disruptive slowdown Q4 was pretty meaningful, even though you had a pretty difficult comparison. Is that really your existing sales force, that's been there for a while focusing on more on the CREO roll out, or is there something else out that's going on right now as far as that business goes?
Rick Baron
I don't look at it as slowing, [indiscernible] Matt. It's Rick. It's really ratio of what comes in, and because you had some bolus of new people come in and the new people come in due to the split of traditional business is a 40% pedicle screw which would be Innovative Fusion. So when you get a bolus of that with a new person, you're going to see that number tick up because it wasn't in that same-store sales the prior year. So it's a little bit of math. We don't view it as having slowed down. The other point to make is that from an overall growth perspective, this is a fairly significant growth from a sequential quarter and a pretty fine uptick for what [indiscernible] $2 million fee. So all of those things add to the way the math is done.
Matthew O'Brien - William Blair
Okay, fair enough.
Rick Baron
I think that was responsive.
Matthew O'Brien - William Blair
No, that's helpful, just along those lines, so as we start to model out for '14, specifically between Innovative Fusion and Disruptives, does it make sense for the first half of the year; Innovative Fusion to go faster than Disruptive, and maybe as those newer reps get the curve [ph], then they start pulling through some of the Disruptive Technologies for that; that growth rate that's split in the back half to be stronger in Disruptive versus Innovative Fusion?
Dave Demski
I think we're going to see the same two factors Rick alluded to. Particularly the first half of the year, both CREO is going to continue to -- we hope continue to get some traction and then as we've added the new reps even in '13, they're going to continue to grow, we hope so. I think you will see the trend more like the fourth quarter as we go into the first half of the year.
Matthew O'Brien - William Blair
Okay just one more, a real quick, and I'll get out of hair. Algea, I know this was kind of a year for you guys, you're expecting to see some good growth out of that business. Just any sense on where we stand from a traction perspective and then and an outlook for '14 and beyond?
Rick Baron
Again we're not going disclose those numbers individually but we grew significantly this year and we have pretty strong plans for 2014 as well.
Your next question comes from David Rollman with Goldman Sachs
David Rollman - Goldman Sachs
I wanted just to come back to Excelsius a little bit. You talked about that in your prepared remarks, but maybe you could just give us some sense on the timelines and what are the key milestones you should be watching to assess the development of the technology?
David Paul
Thank you David. As we mentioned in the press release we expect this product to come to the U.S. market sometime in 2016, like our most products -- all products in our development pipeline, we really don't disclose anything beyond that till we actually get the product out. But we are working to make sure that we can make the timelines fix. So sometime in 2016 is when you can expect the product launch and we won't be speaking any more about intermediate milestones on that.
David Rollman - Goldman Sachs
And so would that include any clinical data? Should we not expect to see anything until the commercial launch?
David Paul
David Rollman - Goldman Sachs
Okay and then maybe just coming back to your cash position, it sounded like you made it very clear a couple of times in the call that you used your debt as a positive attribute. Maybe if you could just help us think about what are the opportunity to deploy that capital in a more efficient way, given where interest rates are and given how fragmented some segments of the supply market look to be. What are your thoughts to sort of start putting that cash to work in a more efficient manner.
Dave Demski
Dave, this is Dave Demski. We're actively looking at opportunities all the time. We're not going to chase it over, pay for something just because we have a strong cash position but we're very interested in opportunities that would add to our technology portfolio or expand our footprint and we're always looking at them. We've already pulled the trigger on a select few at this point.
David Rollman - Goldman Sachs
Okay, and then maybe just one last one for Rick. I wouldn't want him to feel left out here. On the P&L, this is quarterly delivered, very nice, both operating income and earnings growth in comparison to sales growth. I think what you've talked in the past is an intention to be able to grow revenue and earnings roughly at the same pace. But should we look at this quarter as reflective of the type of leverage you can generate over time or should we more be thinking about the business as top line and bottom line pacing at a similar level.
Rick Baron
I think you should go with the latter. This quarter was a really good quarter. We'll call it out. We have to explain the reasons why it was above [indiscernible] growth in sales. There were some bid events on the ability to hold some cost and timing in R&D and things like that. I think you picked a longer term view. We've always suggested and we'll continue to suggest that you got to take a 12 month view of the business. We have though gotten operating leverage. I do think that that's something that is very important and sometimes misunderstood.
At the beginning of the year, with the med device tax we indicated that we would regain the leverage associated with that, which was about 1.6% and we've come, we've been able to pull back on the, not pull back but to increase the growth, the operating margin successfully to do that, which I think is pretty unique out there, especially for a company our size. So embedded with the model is leverage, and then the third element of leverage is that we've always felt that we would reinvest into new businesses, additional shots on goal, which is exactly what we're doing with Exelcius with the additional $6 million to $9 million of R&D. So we're leveraging and then reinvesting, which creates hopefully an extra shot on goal for it to continue double digit growth.
Your next question comes from Rich Newitter with Leerink Swann.
Robert Marcus - Leerink Swann
Hi, afternoon, this is Robbie in for Rich. Just another question maybe on Excelsius. I think in the past you guys have mentioned that the device will be platform agnostic but should have some enhancement for Globus products. Can you maybe provide some more color on that, how that would work, would you be designing new products for it or is it going to be designed to work with the existing portfolio right now?
David Paul
Robbie, thanks for your question. A little bit of both. What we said before still holds. It's going to be designed with an open architecture but it's going to be especially designed to work with the Globus portfolio. So we are working on several key Globus instruments that interface with the robot. It's still in development. So it is going to be specifically tailored to work flawlessly with the Globus systems but also somewhat of an open architecture.
Robert Marcus - Leerink Swann
Okay and then maybe if you could provide some more color on maybe some of the new product launches that we can expect in 2014?
David Paul
Like we've always said, always our goal is to introduce five to 10 new products every year and I think we're well on track to do that for 2014 also. I'm not going to disclose any specific products, but like we have all said always it's going to be singles and doubles, and that's what we're focused on, is innovating it with new products.
Your next question comes from Steven Richman with Oppenheimer & Company.
Steven Richman - Oppenheimer & Company
Just wanted to focus a little bit on the biologic side. Dave, can you talk a little more about the type of contribution you're seeing, KINEX here in the early days and I think you mentioned additional products. Should we be looking for more rollouts from you in biologics in 2014 and should we be focusing on this as a particular nice ramp area for you over the next couple of years.
David Paul
Biologics is an area where we're extremely focused on. We think it's a huge opportunity. So KINEX is just the first of a suite of several products that we have in development and with the FDA. So we are looking forward to launching multiple other products in this space in 2014.
Steven Richman - Oppenheimer & Company
And today biologics is approximately what percent of your total revenue, approximately?
Rick Baron
We don't disclose that. It's an area we can definitely do better in and I think there's a lot of upside for us there.
Steven Richman - Oppenheimer & Company
And then Rick just on the gross margin, obviously international doing very well. How should we be thinking about gross margin specifically as we look at over the next 12 to 18 months? Can that be held flat or should we be thinking a little bit of downward pressure just on mix?
Rick Baron
We've been pretty consistent throughout the year on the margin. I think that the potential is a little bit downward pressure, just because OUS pricing in some of the products that we talked about have pressure on the margin. That's kind of the bad news. The good is from an operating margin contribution, you shouldn't see it. From that perspective you got to think of us as a more mature company, a larger company. We focus more on the operating margin, adjusted EBITDA side that we can get leverage out of.
Thank you for joining the Globus Medical fourth quarter earnings conference call. You may now disconnect.
Copyright policy: All transcripts on this site are the copyright of Seeking Alpha. However, we view them as an important resource for bloggers and journalists, and are excited to contribute to the democratization of financial information on the Internet. (Until now investors have had to pay thousands of dollars in subscription fees for transcripts.) So our reproduction policy is as follows: You may quote up to 400 words of any transcript on the condition that you attribute the transcript to Seeking Alpha and either link to the original transcript or to www.SeekingAlpha.com. All other use is prohibited.
If you have any additional questions about our online transcripts, please contact us at: email@example.com. Thank you!


text:
Hellgate: London
November 2 sees ex-Blizzard dev maestro Bill Roper return with Hellgate: London. Hell's demons have waged war on the Big Smoke in a FPS-RPG that melds sci-fi and fantasy, and the idea of roaming around London and blasting the shit out of stuff is very appealing. The phrase "infinite replayability" is being attached to the title, with the promise of dynamically generated levels, items, enemies and events - so kind of like Diablo. You play a hi-tech Templar Knight character who, as well being a wielder of magic, is additionallytricked out with hefty firepower, armor and plenty of skills to battle Hell's forces.
Check out the Hellgate: London game page here.
PC: The Ones to Watch
Don't avert your eyes from these eye-searing shooters
Hellgate: London
Current page: Page 2Prev Page Page 1 Next Page Page 3
We recommend


text:
Skip to comments.Nobel winner says Arab Spring will banish terror
Posted on 12/09/2011 5:41:39 PM PST by Free ThinkerNY
OSLO, Norway (AP) -- Nobel Peace Prize winner Tawakkul Karman says she believes the pro-democracy revolts that have swept the Arab world will help "drive out" al-Qaida terrorists.
Karman told The Associated Press on the eve of Saturday's award ceremony that the autocratic leaders that were toppled from Tunisia to her native Yemen created an environment where extremism could grow.
(Excerpt) Read more at hosted.ap.org ...
Probably not. The extremists don't have a problem governming with the old Hitler adage, "Kill 100. If that don't work, kill 1000. If that don't work, kill 10,000."
Barry Soetoro is a Nobel Prize "winner" too! It seems to be some kind of a tree house club for morons.
Barry Soetoro is a Nobel Prize winner too! It seems to be some kind of a tree house club for morons.
(worth repeating as I couldn't say it any better)
And Colonel Sanders was a famous vegetarian.
Nobel winner says Arab Spring will banish terror and convert all molems to Christianity
Al-Qaeda won't be "driven out", so much as the Muslim Brotherhood, who originally granted the franchise and supported it through thick and thin for the past twenty years or so, just withdraws its financial and logistical support, and takes over the functions of international terrorism. Now that they have several states to use as a base (Libya, Egypt and soon Syria), they no longer have to hide out in tribal enclaves, and may openly exercise their agenda to create the Worldwide Caliphate.
Which will be based in Jerusalem, as soon as the Jews can be driven out of Israel, and the land reclaimed as Palestine.
"....pro-democracy revolts....?
taqqiya BS at the Nobel ceremonies.
Ronald Reagan won this award too...right? /s
She's a Yemeni. Al taqqiya was her mother's milk.
I'll bet she thinks Disney animated movies are real life depictions too. Oh wait, that would be Disney the infidel, so never-mind.
Well, terrorism against Christians isn't really terrorism in her mind, so she's probably quite accurate. Anything an Islamic lunatic does, could never be termed terrorism, right dear...
I'm sure laureate Yasser Arafat would agree.
Yeah, it has done a helluva job in Egypt. Just ask those women journalists in the crowd.
Karman told The Associated Press on the eve of Saturday's award ceremony that the autocratic leaders that were toppled from Tunisia to her native Yemen created an environment where extremism could grow.It's an environment called "the Domain of Islam".
Arab Spring = Springtime for Hitler
("Arab Spring...manly, yes, but I like it too.")
Tawakkul Karman (L), the chairwoman of Women Journalists without Chains, shouts during an anti-government protest in Sanaa January 29, 2011. Yemen's ruling party has called for dialogue with the opposition, the country's state news agency said late on Friday, in a bid to end anti-government protests fuelled by popular unrest across the Arab World. [Jan 29th, 2011] Reuters/Khaled Abdulla
Very perceptive. Some years back they gave the prize to some woman who actually went around Africa planting trees.
Well, yeah... once you've killed off all your enemies, what need for terror?
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.


text:
Artisan Gourmet Olive Oil Collection Truffles - 12 Pieces
(FREE SHIPPING when purchasing $50 or more - Continental US Only, single address)
In this box: (3) Basil Olive Oil, (3) Raspberry Jalapeno Olive Oil, (3) Blood Orange Olive Oil, (3) Rosemary Olive Oil
Please consume within 3 weeks, we do not use preservatives. We highly suggest freezing to preserve.
When removed from freezer, allow chocolate to reach room temperature before consumption.


text:
J. A. Jance
Judith Ann Jance is an American author of mystery and horror novels. She writes at least three series of novels, centering on retired Seattle Police Department officer J. P. Beaumont, Arizona county sheriff Joanna Brady, and Ali Reynolds. The Beaumont and Brady series intersect in the novel Partner in Crime, which is both the 16th Beaumount mystery and the 10th Brady mystery. They intersect again in Fire and Ice.... more on Wikipedia
J. A. Jance is ranked on...
Authors like Janet Evanovich include writers whose novels are similar, offering readers a hefty dose of humor along with their mystery and suspense. If you've finished Evanovich's popular Stephanie Plum series, you're probably searching for that next great series. Many of the authors listed here might be an option if you like Janet Evanovich. Readers, be sur...
J. A. Jance videos
J.A. Jance - Organizing and Focusing Thoughts
The Art and Business of Writing with J.A. Jance
Mark David Gerson: 1-on-1 with J.A. Jance, NY Times-Bestselling Mystery Author
J. A. Jance


text:
It¡¯s Half Time which nike free Discount Price and High Quality!. 2013 famous Luxury Items Outlet store here which nike free Factory Outlet UK Online, 100% quality guarantee.
executes all orders in his field upon reasonable terms, research neatness and despatch.
Hawley b01 Binghamton Blanchard & Bartlett (C.
A blacksmith shaped his creations of iron by heating the metal and then bending and pounding it to shape it.
Guest Book Goodall, Eveline GOODALL _ Eveline, born in Lynn Valley May 29, 1913, died December 27, 2005.
Survived by her son Roger (Susan), grandchildren Janine, Leslie, Geoffrey (Linda) and Jennifer.
which nike free , Also don't steal from the place you work.
Comments Off Get the WebProNews Newsletter: Are you feeling blue on the day of red candy hearts.
SWl`Y+$%)_ mg6m]ru\GX83CcV\] Y:56"#RqS3&m.
It's not even about getting fired at this point, even though you will get fired for sure, but most will prosecute you at a whim and you might go to prison if it is over 500 dollars total.
We're all a bit blue – mostly because it's freezing and our toes lost circulation around the same time we lost our sight of our cars underneath the snow.
which nike free
It¡¯s New which nike free,Do you do newsletters by email.
By logging into websites, you will be consenting to a cookie that personally identifies anyone to us.
Latest media newsPage: 1 2 3 4 5#The Pharma Letter appoints reporterFrom FeaturesExec Media Bulletin.
What service provider do you think you're the utilization of.
Posted 11 Jul 2014, 16:26The Pharma Letter has appointed Bethany Rutter as reporter.
which nike free
which nike free Member comments tiantianxishi says www.
Have copies to your health records deliver to the surgeon beforehand and bring copies on hand to prevent the and worth of duplicating tests.
concerning tested and it's also real email him for help and up details via: or call +2348107996889 0 from 0 found this comment helpful Was this comment helpful.
And after this we are very happy with 3 kids.
This Web page provides information on the general nature and is designed for educational purposes only.
it is possible to can reach he today on for help 0 from 0 found this comment helpful Was this comment helpful.
In case you have any concerns of your own health or even the health to your child, it is recommended to consult a physician and also other doctor.
nike free run au
cheap nikes online free shipping
nike free run shoes cheap
nike air free 5.0
cheap nike free run 2
nike free run tr 3


text:
Trademark: 'GALLINI'
On 19. 5. 1999 the community trademark application no. 001178748 was filed for GALLINI (Figurative mark) by PAN Rohstoffhandel GmbH before the OAMI.The goods and services in respect of which registration of the trademark was sought are in classes 10, 37 and 42. The current status of the trademark is registered.
Status is 'Registered'
The Community Trade Mark has been registered for the European Union.
|27. 10. 2000
|Expiry date
|19. 5. 2019
|Nice classes
|10, 37, 42
You can follow this trademark. You will receive an email, whenever we detect changes of the trademark filing.
This service is for free. You can unsubsribve whenever you want. More information.